These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9408604

  • 1. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
    Herrlinger U, Kramm CM, Johnston KM, Louis DN, Finkelstein D, Reznikoff G, Dranoff G, Breakefield XO, Yu JS.
    Cancer Gene Ther; 1997; 4(6):345-52. PubMed ID: 9408604
    [Abstract] [Full Text] [Related]

  • 2. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells.
    Yu JS, Burwick JA, Dranoff G, Breakefield XO.
    Hum Gene Ther; 1997 Jun 10; 8(9):1065-72. PubMed ID: 9189764
    [Abstract] [Full Text] [Related]

  • 3. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH, Chen Y, Chang CJ, Tai KF, Lin SM, Hwang LH.
    Clin Cancer Res; 2005 Feb 15; 11(4):1639-49. PubMed ID: 15746069
    [Abstract] [Full Text] [Related]

  • 4. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y, Yamaura A, Sakiyama S, Sato Y, Tagawa M.
    Int J Oncol; 2003 Aug 15; 23(2):483-8. PubMed ID: 12851699
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother; 2001 Aug 15; 24(3):205-11. PubMed ID: 11394497
    [Abstract] [Full Text] [Related]

  • 6. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
    Herrlinger U, Jacobs A, Quinones A, Woiciechowsky C, Sena-Esteves M, Rainov NG, Fraefel C, Breakefield XO.
    Hum Gene Ther; 2000 Jul 01; 11(10):1429-38. PubMed ID: 10910140
    [Abstract] [Full Text] [Related]

  • 7. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H, Villa L, Attanucci J, Erff M, Fellows WK, Lotze MT, Pollack IF, Chambers WH.
    Gene Ther; 2001 Aug 01; 8(15):1157-66. PubMed ID: 11509946
    [Abstract] [Full Text] [Related]

  • 8. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH, Carew JF, Kooby DA, Shields J, Entwisle C, Patel S, Shah JP, Fong Y.
    Cancer Gene Ther; 2000 Sep 01; 7(9):1279-85. PubMed ID: 11023201
    [Abstract] [Full Text] [Related]

  • 9. MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model.
    Herrlinger U, Aulwurm S, Strik H, Weit S, Naumann U, Weller M.
    J Neurooncol; 2004 Jan 01; 66(1-2):147-54. PubMed ID: 15015780
    [Abstract] [Full Text] [Related]

  • 10. Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model.
    Lumniczky K, Desaknai S, Mangel L, Szende B, Hamada H, Hidvegi EJ, Safrany G.
    Cancer Gene Ther; 2002 Jan 01; 9(1):44-52. PubMed ID: 11916244
    [Abstract] [Full Text] [Related]

  • 11. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X, Wang Y, Dietrich MF, Andreeff M, Arlinghaus RB.
    Oncogene; 2006 Jul 27; 25(32):4483-90. PubMed ID: 16547503
    [Abstract] [Full Text] [Related]

  • 12. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
    Wakimoto H, Abe J, Tsunoda R, Aoyagi M, Hirakawa K, Hamada H.
    Cancer Res; 1996 Apr 15; 56(8):1828-33. PubMed ID: 8620500
    [Abstract] [Full Text] [Related]

  • 13. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
    Okada H, Giezeman-Smits KM, Tahara H, Attanucci J, Fellows WK, Lotze MT, Chambers WH, Bozik ME.
    Gene Ther; 1999 Feb 15; 6(2):219-26. PubMed ID: 10435106
    [Abstract] [Full Text] [Related]

  • 14. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
    Shi FS, Weber S, Gan J, Rakhmilevich AL, Mahvi DM.
    Cancer Gene Ther; 1999 Feb 15; 6(1):81-8. PubMed ID: 10078967
    [Abstract] [Full Text] [Related]

  • 15. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
    Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M, Dranoff G.
    Cancer Res; 2000 Jun 15; 60(12):3239-46. PubMed ID: 10866317
    [Abstract] [Full Text] [Related]

  • 16. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
    Newcomb EW, Demaria S, Lukyanov Y, Shao Y, Schnee T, Kawashima N, Lan L, Dewyngaert JK, Zagzag D, McBride WH, Formenti SC.
    Clin Cancer Res; 2006 Aug 01; 12(15):4730-7. PubMed ID: 16899624
    [Abstract] [Full Text] [Related]

  • 17. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD, Chihara H, Kobayashi G, Zhu X, Miller MA, Scott DL, Krieg AM.
    Cancer Res; 2003 Jan 15; 63(2):394-9. PubMed ID: 12543793
    [Abstract] [Full Text] [Related]

  • 18. Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.
    Lefranc F, Cool V, Velu T, Brotchi J, De Witte O.
    Int J Oncol; 2002 May 15; 20(5):1077-85. PubMed ID: 11956607
    [Abstract] [Full Text] [Related]

  • 19. Genetically engineered tumor cell vaccine in a head and neck cancer model.
    Couch M, Saunders JK, O'Malley BW, Pardoll D, Jaffee E.
    Laryngoscope; 2003 Mar 15; 113(3):552-6. PubMed ID: 12616213
    [Abstract] [Full Text] [Related]

  • 20. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K, Papworth GD, Watkins SC, Gambotto A, Yoshida J, Pollack IF, Okada H.
    Gene Ther; 2004 Nov 15; 11(21):1551-8. PubMed ID: 15343358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.